Streetbeat News

Revenues

AVGO

Broadcom (NASDAQ:AVGO) has been analyzed by 31 analysts over the past three months, showing a positive shift in sentiment with an increase in the average 12-month price target to $1512.81 from $1315.00. The ratings range from bullish to indifferent, with a significant number of analysts raising their price targets. Broadcom's financials indicate a strong revenue growth rate of 34.17% as of January 31, 2024, but challenges in net margin, ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 12:00 pm

MDXG

TELA

Tela Bio has sold the distribution rights for its NIVIS Fibrillar Collagen Pack to MiMedx, with an initial payment of $5M and future payments ranging from $3M-$7M based on NIVIS's net sales over the next two years.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 11:13 am

HLF

Herbalife projects Q1 sales growth of 1% to 3% and anticipates full-year 2024 sales growth to range between 0% and 5%.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 11:08 am

VEEV

Veeva Systems announced that its Vault EDC solution has surpassed the 1,000 study start milestone, with significant adoption among top biopharmaceutical companies and CROs. This marks a key achievement in the widespread use of modern electronic data capture (EDC) technologies in the industry.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 11:05 am

GIS

General Mills has reaffirmed its financial outlook for fiscal year 2024, projecting that its organic net sales will range from a 1% decrease to remaining flat. This announcement provides investors with a clear expectation of the company's performance in the near term.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 11:04 am

SIG

Signet Jewelers provided its financial outlook for FY25, projecting revenues of $6.66B to $7.02B, which is below the estimated $7.17B. The company also forecasts EPS to be between $9.08 and $10.48, compared to the estimated $10.57.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:56 am

SIG

Signet Jewelers forecasts Q1 revenue to be between $1.47B and $1.53B, which is at the lower end of the $1.53B estimate. The company also expects same store sales to decrease by 11% to 7%.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:54 am

JILL

J.Jill projects its fiscal year 2024 net sales to remain stable or experience a slight increase in the low-single digits.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:49 am

BNTX

BioNTech forecasts FY2024 sales to be between €2.5B and €3.1B, with R&D expenses projected at €2.4B-€2.6B, SG&A expenses at €700M-€800M, and capital expenditure estimated to be €400M-€500M.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:20 am

BNTX

BioNTech announced the delivery of over 400 million Covid-19 vaccine doses globally in 2023, including a vaccine adapted to the XBB.1.5 variant. This achievement underscores the company's ongoing contribution to combating the pandemic.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:17 am